StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) income statement

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3012% below fair value
$1.01+0.06 (+6.75%)

Close on Nov 19, 2026Market cap $101.20MP/E –Yield –

Stereotaxis, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
55.6%
Operating margin
-75.7%
Net margin
-74.2%
Return on equity, FY2025
-221.3%

Financial strength

Current ratio
1.42
Debt to equity
–
Debt to assets
–
Cash to current liabilities
39.1%

Valuation

P/E ratio
–
Price to sales
3.37
Price to book
8.27
Dividend yield
–

See a number that looks wrong?